VistaGen names Douglas J. Williamson to board of directors
VTGN•VistaGen names Douglas J. Williamson to board of directors
- VistaGen named Douglas J. Williamson to its board of directors.
- Williamson is a CNS drug development consultant, founder of Destiny Biopharm Consulting, and most recently chief medical officer at QurAlis.
- He previously led R&D at Acadia Pharmaceuticals, served as chief medical officer at Avadel, and held senior roles at Lundbeck, Parexel, and Eli Lilly.
